Poland· PL-100365891

Xorimax 500

A cefuroxime product containing cefuroximum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC J01DC02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedXorimax 500ATCJ01DC02REGISTER NO.PL-100365891PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Cefuroxime is registered in 15 of 19 countries.

Countries holding a registration under ATC J01DC02 (cefuroxime), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Cefuroxime · ATC J01DC02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefuroxime costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.0038 in Finland to $4.41 in Switzerland — a ×1160 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cefuroxime · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.41
  • IT Italy$1.06
  • FI Finland$0.0038
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Cefuroximum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
J01DC02
ATC class
Cefuroxime
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991265328

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

210 interactions on record for cefuroxime.

Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefuroxime · interactions on record

210 records

  • 46 moderate
  • 164 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefuroxime in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefuroxime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aprokam, Cefuroxim Aptapharma
  • Belgium · Aprokam, Cefuroxim Fresenius Kabi
  • Bulgaria · Аксетин, Аксеф
  • Cyprus · Axetine, Cefurax
  • Czechia · Aprokam, Axetine
  • Germany · Aprokam, Cefurax
  • Denmark · Aprokam, Cefuroxim B. Braun
  • Estonia · Axetine, Cefuroxime Mip
  • Spain · Cefuroxima Alter, Cefuroxima Cinfa
  • Finland · Aprokam, Cefirion
  • France · Aprokam, Cefuroxime Arrow
  • United Kingdom (Northern Ireland) · Aprokam, Cefuroxime
  • Greece · Anaptivan, Cefur
  • Croatia · Axetine, Beloxim
  • Hungary · Cefuroxim Kabi, Cefuroxime Aptapharma
  • Ireland · Aprok, Ceftal
  • Iceland · Aprokam, Cefuroxim Fresenius Kabi
  • Italy · Aprokam, Cefuroxima K24 Pharmaceuticals
  • Lithuania · Axetine, Cefuroxime Mip
  • Luxembourg · Aprokam, Cefuroxim Fresenius
  • Latvia · Axetine, Cefuroxime Bcpp
  • Malta · Axetine, Cefuroxime Axetil Ccav
  • Netherlands · Aprokam, Cefuroxim Fresenius Kabi
  • Norway · Aprokam, Cefuroxim B. Braun
  • Portugal · Antibioxime, Aprokam
  • Romania · Aprokam, Axetine
  • Sweden · Aprokam, Cefuroxim Mip
  • Slovenia · Aprokam, Cefuroksim Aptapharma
  • Slovakia · Aprokam, Axetine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bcb5b0ac-c726-49fc-9880-2ea45304fd86
GET /v1/drugs/bcb5b0ac-c726-49fc-9880-2ea45304fd86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909991265328 ¦ Rp ¦ 114525\n10 tabl.",
  "substance": "Cefuroximum 500 mg",
  "common_name": "Cefuroximum",
  "pl_product_id": "100365891",
  "pozwolenie_nr": "123/16",
  "auth_procedure": "IR",
  "authorisation_validity": "2026-03-02"
}

See everything about cefuroxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.